AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said AbbVie Inc. (NYSE:ABBV) is a very strong health care provider.
在CNBC的“Halftime Report Final Trades”中，Cerity Partners 的Jim Lebenthal表示AbbVie Inc. (NYSE:ABBV) 是一家非常强大的医疗保健服务提供商。
On July 25, AbbVie reported second-quarter adjusted EPS of $2.65, down 8.9% year over year, beating the consensus of $2.57. Net revenues reached $14.46 billion, up 4.3%, beating the consensus of $14.03 billion. Sales were up 5.6% on an operational basis.
7月25日，AbbVie报告了第二季度调整后的每股收益为2.65美元，同比下降8.9%，高于市场预期的2.57美元，净营业额达到144.6亿美元，同比增长4.3%，超过了市场预期的140.3亿美元。业务运营基础上，销售额增长了5.6%。
Stephen Weiss of Short Hills Capital Partners said Leidos Holdings, Inc. (NYSE:LDOS) reported stable earnings.
Short Hills Capital Partners的Stephen Weiss表示Leidos Holdings，Inc. (NYSE:LDOS) 公布了稳定的收益。
On July 30, Leidos reported better-than-expected second-quarter fiscal 2024 earnings. The company posted revenue growth of 8% year-over-year to $4.13 billion, beating the analyst consensus estimate of $4.06 billion, driven by demand across all customer segments, especially for managed health services.
7月30日，Leidos报告了超出预期的2024财年第二季度收益。公司公布了业务增长，同比增长了8%至41.3亿美元，超过了分析师一致预估的40.6亿美元，需求跨所有客户领域增长，尤其是在医疗服务管理方面。
Don't forget to check out our premarket coverage here
别忘了查看我们的盘前报道。
Stephanie Link of Hightower named iShares U.S. Healthcare ETF (NYSE:IYH) as her final trade.
Hightower的Stephanie Link选择了ishares安硕美国医疗保健ETF（NYSE：IYH）作为她的最后一笔交易。
Joseph M. Terranova of Virtus Investment Partners picked KKR & Co. Inc. (NYSE:KKR).
Virtus Investment Partners的Joseph m. Terranova选择了KKR & Co. Inc. (NYSE:KKR)。
On July 31, KKR & Co posted second-quarter earnings of 72 cents per share on sales of $4.17 billion. On Aug. 2, Citigroup analyst Chris Allen maintained KKR with a Buy rating, while raising the price target from $130 to $150.
7月31日，KKR & Co发布了每股收益为72美分、销售额为41.7亿美元的二季度收益。8月2日，花旗集团分析师Chris Allen 给予KKR买入评级，并将价格目标从130美元上调至150美元。
Price Action:
价格行动：
- AbbVie shares fell 2.6% to close at $184.36 on Monday.
- Leidos gained 0.9% during Friday's session.
- iShares U.S. Healthcare ETF fell 2.6% during Monday's session.
- KKR shares fell 2.2% to settle at $106.23 on Monday.
- AbbVie股价周一下跌2.6%，收于184.36美元。
- Leidos在周五交易中上涨了0.9%。
- ishares安硕美国医疗保健ETF在周一交易中下跌了2.6%。
- KKR股价周一下跌2.2%，收于106.23美元。
- Top 3 Tech Stocks That Could Surge This Quarter
- 本季可能上涨的前3家科技股
Image created using artificial intelligence via Midjourney.
图像由Midjourney通过人工智能创建。